Full length protein (Human) SNX7
Disease areas: mental disorders, birth defects, benign tumor.
Our Abpromise guarantee covers the use of ab37691 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | 1/2000. Predicted molecular weight: 45 kDa. |
ab37691 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"